Elevated morbidity and health care use in children with obstructive sleep apnea syndrome

Ariel Tarasiuk1, Sari Greenberg-Dotan, Tzahit Simon-Tuval

  • 1Department of Physiology, Faculty of Health Sciences, P.O. Box 653, Ben-Gurion University of the Negev, Beer-Sheva, Israel. tarasiuk@bgu.ac.il

Insights

Children diagnosed with obstructive sleep apnea syndrome (OSAS) exhibit increased healthcare utilization and respiratory-related illnesses from their first year of life. Early identification of OSAS in children is crucial for managing associated health issues.

Area of Science:

  • Pediatric Health
  • Sleep Medicine
  • Morbidity Studies

Background:

  • Healthcare utilization is a key indicator of childhood morbidity.
  • Increased healthcare use is observed in preschool children a year prior to obstructive sleep apnea syndrome (OSAS) diagnosis.
  • The age at which OSAS-related morbidity manifests remains unclear.

Purpose of the Study:

  • To investigate morbidity and healthcare use in children diagnosed with OSAS, beginning from their first year of life.
  • To establish the early signs and patterns of health issues associated with OSAS in pediatric populations.
  • To correlate healthcare resource utilization with the onset of OSAS in early childhood.

Main Methods:

  • A case-control study involving 156 children aged 3-5 years diagnosed with OSAS and matched healthy controls.
  • Data collection spanned from the first year of life up to the OSAS diagnosis date.
  • Health records and computerized databases from Clalit Health Care Services were utilized to track diagnoses and healthcare utilization.

Main Results:

  • Children with OSAS showed a 40% increase in hospital visits and a 20% rise in repeated visits compared to controls.
  • Higher consumption of anti-infective and respiratory drugs was noted in the OSAS group (p < 0.0001).
  • Referrals to otolaryngology and pediatric pulmonology specialists were significantly higher from Year 1, peaking in Year 4 (OR, 9.4).

Conclusions:

  • Children with OSAS demonstrate elevated healthcare use, primarily for respiratory conditions, starting from their first year of life.
  • Healthcare providers should recognize the early signs of increased morbidity in infants and young children who later receive an OSAS diagnosis.
  • This highlights the importance of early detection and intervention for OSAS to mitigate long-term health consequences.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...